Verified Nov 2026
Other
·

San Diego, California
·
Since 1996
TriLink BioTechnologies, part of Maravai LifeSciences, is a contract development and manufacturing organization founded in 1996 and headquartered in San Diego, California. With 200–500 employees and estimated revenue of $100–250 million, the company synthesizes nucleic acids, modified nucleotides, and mRNA capping analogs for the therapeutics, vaccines, diagnostics, and biopharmaceutical industries. It opened a GMP enzyme manufacturing facility in Florida in 2026 to support integrated mRNA production from research through commercial scale.
TriLink BioTechnologies, part of Maravai LifeSciences at a glance
Revenue
$100-250M
Est. band
Employees
200-500
Founded
1996
Headquarters
San Diego, California
Certifications
ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Established & active
30 years in operation (founded 1996).
Holds ISO 9001 certification(s) per public sources.
Overview
TriLink BioTechnologies, part of Maravai LifeSciences, is a contract development and manufacturing organization founded in 1996 and headquartered in San Diego, California. With 200–500 employees and estimated revenue of $100–250 million, the company synthesizes nucleic acids, modified nucleotides, and mRNA capping analogs for the therapeutics, vaccines, diagnostics, and biopharmaceutical industries. It opened a GMP enzyme manufacturing facility in Florida in 2026 to support integrated mRNA production from research through commercial scale.
At a glance
Attribute | Detail |
|---|---|
Founded | 1996 |
Headquarters | San Diego, California |
Employees | 200-500 |
Revenue | $100-250M (estimated) |
Certifications | ISO 9001 |
What TriLink BioTechnologies, part of Maravai LifeSciences makes
TriLink manufactures nucleic acids, patented CleanCap® mRNA capping analogs, modified NTPs, plasmid DNA, and oligonucleotides; it holds ISO 9001 certification and complies with ICH Q7 and 21 CFR regulations.
Certifications
TriLink BioTechnologies, part of Maravai LifeSciences is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 9001 — trilinkbiotech.com
Latest developments
2026-09-29 — TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP :: Maravai LifeSciences Holdings, Inc. (MRVI) (maravai.com)
2026-09-28 — 4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company’s Phase I Cell Therapy Program (4basebio.com)
2026-06-16 — TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale :: Maravai LifeSciences Holdings, Inc. (MRVI) (maravai.com)
2025-08-14 — Nucleic acid CDMO TriLink lays off 90 in California as parent Maravai restructures | Fierce Pharma (fiercepharma.com)
2025-06-03 — TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology (quantoom.com)
2025-05-14 — TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines (businesswire.com)
Facilities
TriLink BioTechnologies, part of Maravai LifeSciences is headquartered in San Diego, California. Public sources also reference these locations:
Jupiter, Florida — maravai.com
San Diego, California — americanpharmaceuticalreview.com
Company details
The company is owned by Maravai LifeSciences and serves pharmaceutical companies, biotech firms, government entities, and research organizations in global health and therapeutics development. TriLink BioTechnologies, part of Maravai LifeSciences was founded in 1996, has an estimated 200-500 employees, and is headquartered in San Diego, California. On the LightSource stability read it is rated "Established & active": 30 years in operation (founded 1996). Holds ISO 9001 certification(s) per public sources.
Frequently asked questions
What does TriLink BioTechnologies, part of Maravai LifeSciences do?
TriLink BioTechnologies, part of Maravai LifeSciences, is a contract development and manufacturing organization founded in 1996 and headquartered in San Diego, California. With 200–500 employees and estimated revenue of $100–250 million, the company synthesizes nucleic acids, modified nucleotides, and mRNA capping analogs for the therapeutics, vaccines, diagnostics, and biopharmaceutical industries. It opened a GMP enzyme manufacturing facility in Florida in 2026 to support integrated mRNA production from research through commercial scale.
Where is TriLink BioTechnologies, part of Maravai LifeSciences headquartered?
TriLink BioTechnologies, part of Maravai LifeSciences is headquartered in San Diego, California (10770 Wateridge Cir, San Diego, California, 92121-5701).
When was TriLink BioTechnologies, part of Maravai LifeSciences founded?
TriLink BioTechnologies, part of Maravai LifeSciences was founded in 1996.
How big is TriLink BioTechnologies, part of Maravai LifeSciences?
TriLink BioTechnologies, part of Maravai LifeSciences has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).
What certifications does TriLink BioTechnologies, part of Maravai LifeSciences hold?
TriLink BioTechnologies, part of Maravai LifeSciences lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
